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This  study  was  designed  to evaluate  whether  NADPH  oxidase  inhibitor  (apocynin)  preconditioning
induces expression  of Src  homology-2  domain-containing  phosphatase-1  (SHP-1)  to  protect  against  renal
ischemia/reperfusion  (I/R)  injury  (RI/RI)  in  rats. Rats  were  pretreated  with  50 mg/kg  apocynin,  then  sub-
jected to  45  min  ischemia  and  24  h  reperfusion.  The  results  indicated  that  apocynin  preconditioning
improved  the recovery  of renal  function  and  nitroso-redox  balance,  reduced  oxidative  stress  injury  andeywords:
ADPH oxidase inhibitor (apocynin)
schemia/reperfusion (I/R)
enal ischemia/reperfusion injury (RI/RI)
HP-1
reconditioning
inﬂammation  damage,  and  upregulated  expression  of  SHP-1  as compared  to RI/RI  group.  Therefore  our
study  demonstrated  that  apocynin  preconditioning  provided  a protection  to the kidney  against  I/R  injury
in  rats  partially  through  inducing  expression  of SHP-1.
©  2015  The  Authors.  Published  by Elsevier  Ireland  Ltd.  This  is an open  access  article  under  the CC
BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).. Introduction
Ischemia/reperfusion (I/R)-induced injury was a primary reason
f acute organ dysfunction and that usually occured in association
ith pathophysiological conditions, including primary surgery,
rauma, large area burns, and acute hypovolemia due to heavy ﬂuid
nd blood loss [1]. Although reperfusion after ischemia generally
mproved the recovery of organ dysfunction caused by ischemia, in
ome instances, reperfusion may  aggravate the damage associated
ith ischemia [2].
Renal ischemia/reperfusion injury (RI/RI) was mediated by mul-
iple pathophysiological mechanisms of which free radical damage
nd NO were two key events [3,4]. During RI/RI, free radicals were
ncreased and NO was reduced, resulting in extensive damage and
poptosis of tubular epithelial cells [5,6]. Among these factors,
rc homology-2 domain-containing phos-phatase-1 (SHP-1) was
nvolved in the pathophysiology of damage and apoptosis through
ultiple signaling pathways [7–9].
Src homology-2 domain-containing phosphatase-1 (SHP-1) was
rst identiﬁed [10] as a protein tyrosine phosphatase contain-
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c-nd/4.0/).ing two tandem SH2 domains later shown to have targeting and
regulatory functions [11]. Literatures demonstrated that the intra-
cellular protein tyrosine phosphatase (PTP) known as SHP-1 may
regulate macrophage activation [8]. Previous study also demon-
strated that SHP-1, a PTP that was  critical in abating cell response
to growth factors, was  elevated in renal cortex by diabetes [12].
SHP-1 had been shown to inhibit vascular endothelial growth fac-
tor (VEGF) actions in renal glomeruli of diabetic rats and mice [13].
However, Ischemia/reperfusion (I/R) injury produced a lot of oxy-
gen free radicals (OFR) and these elevated level of OFR can inhibit
the phosphatase activity of SHP-1, and the function of SHP-1 was
restrained to promote the release of OFR [7,8]. During the early
IR period of lung transplantation, the activity of PTP was reduced
[14]. Present study indicated that RI/RI can produce lots of OFR
[6] and inﬂammatory factors [15] which can inhibit the activity
of SHP-1, and loss of activity of SHP-1 can further exacerbate the
damage of RI/RI [9,16–18]. These researches suggested that this
renal protective effect was  at least in part by activation of SHP-1.
The aforementioned results manifested that SHP-1 played different
roles in different tissues or organs during I/R injury.
On the other hand, SHP-1 negatively regulated Toll-like
receptor-mediated production of proinﬂammatory cytokines by
inhibiting activation of the transcription factor NF-kappaB [9].
It was  known that Toll-like receptors (TLRs) were a family of
transmembrane proteins that in addition to binding to a range of
 article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
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Aig. 1. Serum levels of BUN and Scr. The blood of sham, RI/RI, RI/RI + apocynin grou
xpressed as mean ± SD. (A) a signiﬁcant increase from sham group was  denoted b
ncrease  from sham group was  denoted by“*” (p < 0.01), a signiﬁcant decrease from
icrobial products can also recognize endogenous ligands termed
anger-associated molecular patterns (DAMPs) [19]. After TLR
ctivation an intracellular cascade of events occured resulting in the
elease of NF-B from IB, allowing NF-B translocation from cyto-
lasm to nucleus where it mediated the increase in inﬂammatory
ytokine gene expression leading to pro-inﬂammatory responses
20–23]. Documents conﬁrmed that TLR4/NF-B  p65 signal path-
ay was activated to promote renal damage on kidney ischemia
eperfusion injury [19], and SHP-1 can negatively regulated TLR4
ignal pathway to inhibit the product of downstream proinﬂam-
atory cytokines (TNF-ɑ)  [9].
Apocynin was a naturally occurring methoxy-substituted cate-
hol that effectively inhibits NADPH oxidase through preventing
he assembly of its multi-subunits [24]. Protective effects of
pocynin had been observed when administered before ischemia
preconditioning) [25]. Increased attention had been paid to
he protective effects of apocynin on I/R injury to the testicle,
eart, neuro, brain, and kidney. In testicular I/R injury, pre-
onditioning with apocynin reduced the production of oxygen
ree radicals and improved these histological alterations [26].
reconditioning with apocynin also reduced myocyte inﬂamma-
ory response and cell apoptosis after myocardial I/R-induced
njury [27,28]. Preconditioning with apocynin in animal models
ad also been reported to provide protection through reduc-
ng the production of oxygen free radicals from I/R-induced
enal injury [29]. Present literatures also demonstrated that
pocynin can ameliorate nitroso-redox unbalance and regu-
ate TLR4 expression on myocardial ischemia reperfusion injury
27].
Thus, apocynin may  exert protective effects against
schemia/reperfusion injury in many organs, including the kidney.
lso, in different ischemia/reperfusion models, the role of SHP-1
aried. However, to date, no studies had inspected the effects
etween apocynin and SHP-1 on renal ischemia/reperfusion
njury. Therefore, in this preliminary study, we  inquired into
HP-1 how to participate in the possible protective effects of
pocynin preconditioning on renal ischemia/reperfusion injury in
ats.
. Materials and methods
.1. Animals and reagents
Sprague-Dawley (SD) rats (180–220 g) were supplied by the
nimal research center of Lanzhou university medical college,
anzhou, China. All the procedures and care administered to the
nimals had been approved by the institutional ethic committee.
ll reagents and drugs were purchased from Sigma.ts was  collected after reperfusion 24 h and level of BUN and Scr measured. Results
p < 0.01), a signiﬁcant decrease from RI/RI group, by“#” (p < 0.01); (B) a signiﬁcant
group, by“#” (p < 0.01)
2.2. Animal experimental design
In the pilot experiment, 5 rats were in sham group and 15 rats
underwent RI/RI. 12 h (n = 5), 24 h (n = 5) and 48 h (n = 5) after reper-
fusion, the rats were euthanized, and kidneys were collected. In the
formal experiments, 30 SD rats were randomly assigned to three
groups (each group had 10 rats): sham, RI/RI and RI/RI + apocynin.
The rats in RI/RI + apocynin groups injected apocynin (50 mg/kg)
through intraperitoneal injection 30 min  before reperfusion. The
doses were selected based on previous reports [30].
2.3. Surgical procedures of RI/RI
Rats were anesthetized with 1% pentobarbital sodium
(60 mg/kg) through injecting in enterocoelia. The enterocoelia was
opened and the bilateral renal artery and vein were separated. The
artery and vein were occluded for 45 min  by two  artery clamps,
and the success was  conﬁrmed by observing the color changing
of the kidneys. The artery clamp was removed 45 min  later and
renal artery and vein were allowed reperfusion for 24 h. The blood
samples were collected via abdominal aorta, and centrifuged at
3600 × g for 10 min  to harvest the sera. The left kidneys of animals
were removed immediately. Renal homogenate from each group
were used to stored at −20 ◦C for the analyses below, respectively.
2.4. Measurement of serum BUN and Scr
The methods had been described previously [4]. Brieﬂy, the
blood of abdominal aorta was  collected after reperfusion 24 h and
centrifuged at 3600 × g for 10 min  to harvest the sera. The BUN and
Scr of serum were measured by O-phthalaldehyde and Picric acid
method.
2.5. Measurement of SOD activity and MDA content
The levels of SOD and MDA  in tissues were measured to assess
lipid peroxidation as described previously [4]. The kidney specimen
was collected after reperfusion 24 h and the blood of tissues was
washed cleanly, homogenized (100 mg)  in ice normal saline and
made into 10% homogenate, then centrifuged at 3600 × g for 10 min
to harvestthe supernatant. The SOD activity and MDA  content were
measured by xanthine oxidase and thiobarbituric acid method.The
absorbance was measured at 550 and 532 nm.  The level of lipid
peroxides was expressed as U of SOD/mg prot and nmol of MDA/mg
tissue.2.6. Measurement of TNF-  ˛ content
The levels of TNF- in tissues were measured to assess inﬂam-
matory injury as described previously [31]. The samping process
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Fig. 2. The activity of SOD and the level of MDA  in renal tissues. The renal tissues of sham,
of  SOD and level of MDA  measured. Results expreed as mean ± SD. (A) a signiﬁcant decre
group,  by“#” (p < 0.01); (B) a signiﬁcant increase from sham group was denoted by“*” (p <



















gI/RI + apocyningroups rats were collected after reperfusion 24 h and level of TNF-
 measured. Results expreed as mean ± SD. A signiﬁcant increase from sham group
as  denoted by“*” (p < 0.01), a signiﬁcant decrease from RI/RI group, by“#” (p < 0.01)
as the same as above and the TNF- content was measured by
ouble antibody sandwich ELISA method. The absorbance was  mea-
ured at 495 nm.  The level of inﬂammatory injury was  expressed
s ng of TNF-/g tissue.
.7. Measurement of NO content and iNOS activity
The methods had been described previously [3]. The samping
rocess was the same as above, the NO content and iNOS activity
ere measured by nitrale reduetase and absorption photometry.
he absorbance was measured at 550 nm and 530 nm.  The levels of
O and iNOS were expressed as nmol of NO/g and U of iNOS/mg
issue.
.8. Western blot analysisThe methodology had been described previously [20,32,33].
irstly, we demonstrated that the expression of SHP-1 in
he kidney of rats with RI/RI was downregulated. 5 rats in
ig. 4. The level of NO and the activity of iNOS in renal tissues. The renal tissues of sham,R
O  and activity of iNOS measured. Results expreed as mean ± SD. (A) a moderately increa
roup,  by“#” (p < 0.01); (B) a signiﬁcant increase from sham group was denoted by“*” (p < RI/RI, RI/RI + apocynin groups rats were collected after reperfusion 24 h and activity
ase from sham group was  denoted by“*” (p < 0.01), a signiﬁcant increase from RI/RI
 0.01), a signiﬁcant decrease from RI/RI group, by“#” (p < 0.01)
sham group and 15 rats underwent RI/RI. 12 h, 24 h and 48 h
after reperfusion, the kidneys removed after the rats were
culled. Renal tissues were homogenized in protein lysate buffer.
The homogenates were resolved on polyacryl-amide SDS gels,
and electrophoretically transferred to polyvinylidene diﬂuoride
membranes. The membranes were blocked with 3% BSA, incubated
with primary Abs against active SHP-1, and subsequently with alka-
line phosphatase-conjugated secondary Abs. They were developed
by 5-b-romo-4-chloro-3-indolyl phosphate/nitro blue tetrazolium.
Blots were stained with anti-GAPDH Ab, and the levels of pro-
teins were normalized with respect to GAPDHb and density. In
the formal experiments, the kidney specimen was collected after
reperfusion 24 h and was homogenized in protein lysate buffer.
The homogenates were resolved on polyacryl-amide SDS gels, and
electrophoretically transferred to polyvinylidene diﬂuoride mem-
branes. The membranes were blocked with 3% BSA, incubated with
primary Abs against active SHP-1, TLR4, NF-B, and subsequently
with alkaline phosphatase-conjugated secondary Abs. They were
developed by 5-b-romo-4-chloro-3-indolyl phosphate/nitro blue
tetrazolium. Blots were stained with anti-GAPDH Ab, and the levels
of proteins were normalized with respect to GAPDHb and density.
2.9. Statistical analysis
All the data was expressed as mean values ± standard devia-
tion (SD). Statistical analysis between groups was carried out using
ANOVA with post-hoc testing. A value of less than 0.01 (p < 0.01)
was used for statistical signiﬁcance.
3. Result3.1. Serum level of BUN and Scr
The serum level of BUN in RI/RI rats was signiﬁcantly higherthan
that in sham group (p < 0.01). The levels of BUN  ranged from 2.54
I/RI, RI/RI + apocynin groups rats were collected after reperfusion 24 h and level of
se from sham group was denoted by“*” (p < 0.05), a signiﬁcant increase from RI/RI
 0.01), a signiﬁcant decrease from RI/RI group, by“#” (p < 0.01)
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Fig. 5. The expression of SHP-1, TLR4 and NF-B in renal tissues. In the pilot
experiment, the renal tissues of sham, RI/RI (12 h), RI/RI (24 h), RI/RI (48 h) groups
rats  were collected and the expression of SHP-1 measured. Results expreed as
mean ± SD. (A) a signiﬁcant decrease from sham group was denoted by “*” (p < 0.01),
a  further signiﬁcant decrease from RI/RI group, by “#” (p < 0.01); (B) in the formalrts 2 (2015) 1111–1116
to 3.18 mol  (2.91 ± 0.25 mol) in sham group, whereas the level
of BUN reached 28.29 ± 1.58 mol  in RI/RI group. Administration
of RI/RI + apocynin group signiﬁcantly reduced the levels of BUN
(14.21 ± 1.07 mol) compared with RI/RI group (p < 0.01) (Fig. 1A).
The serum level of Scr in RI/RI rats was  signiﬁcantly higher than
that in sham group (p < 0.01). The levels of Scr ranged from 45.34 to
50.04 mol  (48.12 ± 2.10 mol) in sham group, whereas the level
of Scr reached 169.72 ± 1.59 mol  in RI/RI group. Administration
of RI/RI + apocynin group signiﬁcantly reduced the levels of Scr
(105.44 ± 5.56 mol) compared with RI/RI group (p < 0.01) (Fig. 1B).
3.2. The activity of SOD and the level of MDA in renal tissues
The activity of SOD in renal tissues which was induced by RI/RI
was signiﬁcantly less than that in sham group (p < 0.01). The activ-
ity of SOD in renal tissues reached 74.31 ± 1.23 U in sham group,
whereas the activity of SOD in renal tissues reached 23.68 ± 1.46
U in RI/RI group. Administration of RI/RI + apocynin group sig-
niﬁcantly increased the activity of SOD (37.39 ± 1.73 U) in renal
tissues, compared with the activity of SOD in renal tissues by RI/RI
group induced (p < 0.01) (Fig. 2A). The level of MDA  in renal tissues
which was  induced by RI/RI was  signiﬁcantly higher than that in
sham group (p < 0.01). The level of MDA  in renal tissues reached
4.93 ± 0.59 nmol in sham group, whereas the level of MDA  in renal
tissues reached 12.02 ± 0.95 mol  in RI/RI group. Administration
of RI/RI + apocynin group signiﬁcantly reduced the level of MDA
(9.16 ± 0.15 mol) in renal tissues, compared with the level of MDA
in renal tissues by RI/RI group induced (p < 0.01) (Fig. 2B).
3.3. The level of TNF-  ˛ in renal tissues
As shown in Fig. 3, the level of TNF- in renal tissues which
was induced by RI/RI was signiﬁcantly higher than that in sham
group (p < 0.01). The level of TNF- in renal tissues reached
0.3785 ± 0.0023 ng in sham group, whereas the level of TNF- in
renal tissues reached 1.135 ± 0.0036 ng by RI/RI group induced.
Administration of RI/RI + apocynin signiﬁcantly reduced the level
of TNF- (0.7024 ± 0.0039 ng) in renal tissues, compared with the
level of TNF- in renal tissues by RI/RI group induced (p < 0.01).
3.4. The level of NO and the activity of iNOS in renal tissues
The level of NO in renal tissues which was  induced by RI/RI was
moderately higher than that in sham group (p < 0.05). The level
of NO in renal tissues reached 7.78 ± 0.40 mol in sham group,
whereas the level of NO in renal tissues reached 10.40 ± 0.48 umol
by RI/RI group induced. Administration of RI/RI + apocynin group
signiﬁcantly increased the level of NO (14.66 ± 0.45 mol) in renal
tissues, compared with the level of NO in renal tissues by RI/RI
group induced (p < 0.01) (Fig. 4A). The activity of iNOS in renal
tissues which was  induced by RI/RI was  signiﬁcantly higher than
that in sham group (p < 0.01). The activity of iNOS in renal tissues
reached 0.45 ± 0.05 U in sham group, whereas the activity of iNOS in
renal tissues reached 1.20 ± 0.07 U by RI/RI group induced. Admin-
experiments, the renal tissues of sham, RI/RI, RI/RI + apocynin groups rats were col-
lected after reperfusion 24 h and measured the expression of SHP-1. Results expreed
as  mean ± SD. A signiﬁcant decrease from sham group was denoted by “*” (p < 0.01),
a  signiﬁcant increase from RI/RI group, by “#” (p < 0.01); (C) in the formal experi-
ments, the renal tissues of sham, RI/RI, RI/RI+apocynin groups rats were collected
after reperfusion 24 h and measured the expression of TLR4. Results expreed as
mean ± SD. A signiﬁcant increase from sham group was denoted by “*” (p < 0.01),
a  signiﬁcant decrease from RI/RI group, by “#” (p < 0.01); (D) in the formal experi-
ments, the renal tissues of sham, RI/RI, RI/RI + apocynin groups rats were collected
after reperfusion 24 h and the expression of NF-B measured. Results expreed as
mean ± SD. A signiﬁcant increase from sham group was denoted by “*” (p < 0.01), a
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stration of RI/RI + apocynin group signiﬁcantly reduced the activity
f iNOS (0.93 ± 0.04 U) in renal tissues, compared with the activity
f iNOS in renal tissues by RI/RI group induced (p < 0.01) (Fig. 4B).
.5. The expression of SHP-1, TLR4 and NF-B in renal tissues
In the pilot experiment, expression of SHP-1 in renal tis-
ues which was induced by renal ischemia/reperfusion for 12 h,
4 h and 48 h was signiﬁcantly less than that in sham group
p < 0.01–0.05), and the expression of SHP-1 was not signiﬁcant dif-
erence between 24 h and 48 h in ischemia/reperfusion (p > 0.05)
Fig. 5A); In the formal experiments, expression of SHP-1 in renal
issues which was induced by RI/RI was signiﬁcantly less than
hat in sham group (p < 0.01). Administration of RI/RI + apocynin
igniﬁcantly upregulated expression of SHP-1 in renal tissues, com-
ared with expression of SHP-1 in renal tissues by RI/RI group
nduced (p < 0.01) (Fig. 5B). In the formal experiments, expression
f TLR4 in renal tissues which was induced by RI/RI was signiﬁ-
antly higher than that in sham group (p < 0.01). Administration of
I/RI + apocynin signiﬁcantly downregulated expression of TLR4 in
enal tissues, compared with expression of TLR4 in renal tissues by
I/RI group induced (p < 0.01) (Fig. 5C); In the formal experiments,
xpression of NF-KB in renal tissues which was induced by RI/RI was
igniﬁcantly higher than that in sham group (p < 0.01). Administra-
ion of RI/RI + apocynin signiﬁcantly downregulated expression of
F-B in renal tissues, compared with expression of NF-B in renal
issues by RI/RI group induced (p < 0.01) (Fig. 5D);
. Discussion
In this preliminary inspection we demonstrated that a main pre-
onditioning regimen involving injected apocynin provided some
rotection against RI/RI in rats. These protective roles were showed
y less pronounced increases in serum BUN and Scr contents after
/R injury. Further, these protective roles appeared to be due, at
east in part, to fortiﬁed renal expression of SHP-1, the expression
f which was reduced after I/R injury in rats that did not adopt pre-
onditioning with apocynin. In addition, in the pilot experiment,
e demonstrated that the expression of SHP-1 in renal tissues was
eally reduced in I/R for different time. Although the detailed mech-
nisms underlying these roles remain to be illuminated, it was
nown that SHP-1 was  involved in regulating signaling cascades
elated to cellular apoptosis and oxidative stress injury.
RI/RI was a common pathophysiological phenomenon and a pri-
ary reason of acute renal failure, which was associated with a high
ortality [1]. Patients who underwent RI/RI may  be subjected to
hronic renal dysfunction of variable severity. RI/RI may  occur dur-
ng kidney surgery, or as a consequence of blood loss, hypotensive
hock, or extracorporeal shock-wave lithotomy [1]. Thus, weaken-
ng or preventing RI/RI had been of signiﬁcant clinical interest.
Previous studies with apocynin had shown protective roles
n the testicle, heart, and kidney [23–26]. These protective roles
ainly involved generalized melioration of nitroso-redox unbal-
nce and oxidative stress injury, although the particular cells and
olecular mechanisms involved either varied or were unknown.
n our study, apocynin can ameliorate renal function and reduced
xidative stress injury, the result was consistent with the liter-
ture [29]. In addition, apocynin can reduce the activity of iNOS
n myocardial ischemia reperfusion injury [34]. Our study demon-
trated that apocynin can reduce the activity of iNOS and increase
he level of NO (eNOS induced, it was consistent with the literature
35] to protect renal injury against ischemia reperfusion induced.
herefore, apocynin can ameliorate nitroso-redox unbalance to
rotect kidney on RI/RI.rts 2 (2015) 1111–1116 1115
TLRs were a family of pattern-recognition receptors that enable
the recognition of conserved structural motifs in a broad array of
pathogens [20]. Several pieces of evidence conﬁrmed that TLR4-
deﬁcient mice were protected against ischemic kidney damage and
injury [36]. TLR4 signals through MyD88, leading to subsequent
downstream activation of NF-B and MAPK signaling pathways
[37]. These signaling cascades are involved in the induction of
proinﬂamma-tory cytokines and chemokines [38]. NF-B was  nor-
mally sequestered in an inactiveform in the cytoplasm bound to IB
proteins, an interaction that regulated its activity [20–22]. Multi-
plestimuli can activate NF-B signaling by degradation of IB and
release of the NF-B p65–p50 dimer, which translocated to the
nucleus, binds to B binding sites on DNA, and regulated trans-
criptional activation of the target genes [39–43]. NF-B was an
important nuclear transcription factor in eukaryotic cells, which
existed in almost all the cells [20]. Inhibiting NF-B activation or
knocking out p50 subunit of NF-B was protection and developed
smaller infarct volume [20]. A critical role of NF-B was to reg-
ulate the genes of inﬂammatory mediators such as TNF-, all of
which play an important role in ischemic renal damage [20,21]. Lit-
erature showed that apocynin can reduce the expression of TLR4
on myocardial ischemia reperfusion injury [34]. Our study demon-
strated that apocynin can downregulate the expression of TLR4 on
renal ischemia reperfusion injury. It hinted that apocynin can mod-
ulate the TLR4 of TLR4/MAPK/NF-B signaling pathway to decrease
the inﬂammatory damage on RI/RI.
SHP-1 was  an intracellular protein tyrosine phosphatase (PTP)
which was  widely expressed in the body, SHP-1 can negatively
regulated TLR4 to modulate TLR4/MAPK/NF-B signaling pathway
[9]. It hinted that inﬂammatory damage was  reduced partially via
upregulating the expression of SHP-1 on RI/RI. Our study demon-
strated that apocynin can upregulate the expression of SHP-1 on
RI/RI. These results illustrated that apocynin can decrease the
inﬂammatory damage partially through upregulating the expres-
sion of SHP-1 to regulate TLR4/MAPK/NF-B signaling pathway on
RI/RI.
This research had several restrictions. For this preliminary
inspection, only a small number of rats were used each group,
which may  have inﬂuenced the statistical capacity of our analy-
ses. Further, we  did not accomplish any histological examination
to analyze the renal damage. Finally, we did not accomplish any
evaluations of cell apoptosis, which would have been the mostly
likely mediators of the surveyed roles in the kidneys of rats with
RI/RI.
In conclusion, we found that apocynin preconditioning
improved renal function in rats following RI/RI, and upregulated
the expression of renal SHP-1. Further studies were needed to
explore whether the renal protective roles of apocynin precondi-
tioning were due to partially upregulated expression of SHP-1 in
the kidney.
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